In8Bio Inc
(INAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 30,667 | 30,337 | 28,521 | 14,653 | 8,557 |
| Operating Income | -30,667 | -30,337 | -28,521 | -14,653 | -8,557 |
| Other Income | 230 | 330 | 0 | 0 | 0 |
| Pre-tax Income | -30,437 | -30,007 | -28,521 | -14,653 | -8,557 |
| Net Income Continuous | -30,437 | -30,007 | -28,521 | -14,653 | -8,557 |
| Net Income | $-30,437 | $-30,007 | $-28,521 | $-14,653 | $-8,557 |
| EPS Basic Total Ops | -17.12 | -30.03 | -40.84 | -44.14 | -90.69 |
| EPS Basic Continuous Ops | -17.07 | -30.17 | -40.85 | -44.14 | -75.16 |
| EPS Diluted Total Ops | -17.12 | -30.03 | -40.84 | -44.14 | -90.69 |
| EPS Diluted Continuous Ops | -17.07 | -30.17 | -40.85 | -44.14 | -75.16 |
| EPS Diluted Before Non-Recurring Items | -16.52 | -30.03 | -40.84 | -44.14 | N/A |
| EBITDA(a) | $-28,012 | $-27,836 | $-27,418 | $-13,865 | $-8,469 |